[PHARMA] QoQ TTM Result on 31-Mar-2013 [#1]

Announcement Date
15-May-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Mar-2013 [#1]
Profit Trend
QoQ- -6.34%
YoY- -11.57%
Quarter Report
View:
Show?
TTM Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 1,946,639 1,861,183 1,846,836 1,865,940 1,812,346 1,697,728 1,642,700 11.94%
PBT 92,997 64,238 79,270 97,283 103,314 115,434 102,587 -6.31%
Tax -36,236 -36,212 -29,878 -37,985 -40,108 -32,578 -34,308 3.70%
NP 56,761 28,026 49,392 59,298 63,206 82,856 68,279 -11.55%
-
NP to SH 55,200 26,453 47,949 57,797 61,711 81,587 67,151 -12.21%
-
Tax Rate 38.96% 56.37% 37.69% 39.05% 38.82% 28.22% 33.44% -
Total Cost 1,889,878 1,833,157 1,797,444 1,806,642 1,749,140 1,614,872 1,574,421 12.90%
-
Net Worth 486,672 473,402 480,568 484,829 472,037 496,469 481,394 0.72%
Dividend
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Div 41,446 37,168 41,172 41,189 41,188 64,713 52,948 -15.02%
Div Payout % 75.08% 140.51% 85.87% 71.27% 66.74% 79.32% 78.85% -
Equity
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Net Worth 486,672 473,402 480,568 484,829 472,037 496,469 481,394 0.72%
NOSH 258,868 258,689 258,370 117,676 117,715 117,646 117,700 68.87%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 2.92% 1.51% 2.67% 3.18% 3.49% 4.88% 4.16% -
ROE 11.34% 5.59% 9.98% 11.92% 13.07% 16.43% 13.95% -
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 751.98 719.47 714.80 1,585.65 1,539.60 1,443.07 1,395.66 -33.71%
EPS 21.32 10.23 18.56 49.11 52.42 69.35 57.05 -48.02%
DPS 16.01 14.37 15.94 35.00 35.00 55.00 44.99 -49.68%
NAPS 1.88 1.83 1.86 4.12 4.01 4.22 4.09 -40.35%
Adjusted Per Share Value based on latest NOSH - 117,676
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 135.07 129.14 128.14 129.47 125.75 117.80 113.98 11.94%
EPS 3.83 1.84 3.33 4.01 4.28 5.66 4.66 -12.22%
DPS 2.88 2.58 2.86 2.86 2.86 4.49 3.67 -14.88%
NAPS 0.3377 0.3285 0.3334 0.3364 0.3275 0.3445 0.334 0.73%
Price Multiplier on Financial Quarter End Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 -
Price 4.45 4.82 4.49 8.26 8.10 7.55 10.18 -
P/RPS 0.59 0.67 0.63 0.52 0.53 0.52 0.73 -13.19%
P/EPS 20.87 47.14 24.19 16.82 15.45 10.89 17.84 10.99%
EY 4.79 2.12 4.13 5.95 6.47 9.19 5.60 -9.86%
DY 3.60 2.98 3.55 4.24 4.32 7.28 4.42 -12.75%
P/NAPS 2.37 2.63 2.41 2.00 2.02 1.79 2.49 -3.23%
Price Multiplier on Announcement Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 06/11/12 08/08/12 -
Price 4.29 4.72 4.66 9.26 7.80 8.25 8.83 -
P/RPS 0.57 0.66 0.65 0.58 0.51 0.57 0.63 -6.43%
P/EPS 20.12 46.16 25.11 18.85 14.88 11.90 15.48 19.04%
EY 4.97 2.17 3.98 5.30 6.72 8.41 6.46 -15.99%
DY 3.73 3.04 3.42 3.78 4.49 6.67 5.09 -18.67%
P/NAPS 2.28 2.58 2.51 2.25 1.95 1.95 2.16 3.66%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment